Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Total 13F shares
-
319,344,550
-
Share change
-
+9,863,634
-
Total reported value
-
$1,830,820,509
-
Put/Call ratio
-
63%
-
Price per share
-
$5.73
-
Number of holders
-
269
-
Value change
-
+$26,198,276
-
Number of buys
-
150
-
Number of sells
-
129
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2025
As of 30 Jun 2025,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
319,344,550 shares.
The largest 10 holders included
VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., Avoro Capital Advisors LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Vestal Point Capital, LP, STATE STREET CORP, MACQUARIE GROUP LTD, MILLENNIUM MANAGEMENT LLC, and PERCEPTIVE ADVISORS LLC.
This page lists
269
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.